-
Dec 2, 2024 | 00303-4&sz=64)
cell.com | Despoina Kosmara |Maria Semitekolou |George Bertsias |Elpida Neofotistou-Themeli
References1. Forsyth, K.S. ... The conneXion between sex and immune responsesNat. Rev. Immunol. 2024; 24:487-5022. Potluri, T. ... Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and femalesNPJ Vaccines. 2019; 4:293. Ubeda, F. ∙ Jansen, V.A.The evolution of sex-specific virulence in infectious diseasesNat. Commun. 2016; 7:138494. Li, J. ... Histone demethylase KDM5D upregulation drives sex differences in colon cancerNature. 2023; 619:632-6395. Conrad, N. ...
-
Oct 21, 2024 | 
ard.bmj.com | Antonis Fanouriakis |George Bertsias |Dimitrios T. Boumpas
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Oct 5, 2024 | 
ard.bmj.com | Marta Mosca |George Bertsias |David Isenberg |Annegret Kuhn
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Sep 30, 2024 | 
ard.bmj.com | Antonis Fanouriakis |Myrto Kostopoulou |George Bertsias |Dimitrios T. Boumpas
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Sep 19, 2024 | 
ard.bmj.com | Antonis Fanouriakis |George Bertsias |Dimitrios T. Boumpas
Lupus Erythematosus, Systemic Therapeutics Lupus Nephritis We thank Drs Roberts et al for their interest in the updated EULAR recommendations for the management of systemic lupus erythematosus (SLE), and for the important points they raise.1 Prompted by a phrase in the manuscript text, that race, as an ‘immutable’ characteristic, should be taken into account during the choice of therapy for an individual patient with SLE, they argue that racial differences in treatment responses or other...
-
May 22, 2024 | 
ard.bmj.com | Myrto Kostopoulou |Chetan Mukhtyar |George Bertsias |Dimitrios T. Boumpas
DiscussionFor the recent update of the EULAR recommendations for the management of SLE, we performed five different SLRs based on respective PICOs, to cover the most important aspects in the treatment of this challenging disease. HCQ is the backbone treatment for all patients with SLE, while GC are still used in the majority of patients. The current SLR confirmed the beneficial effects of HCQ in lupus, ranging from prevention of infections or thrombosis to improved survival.
-
Apr 5, 2024 | 
ard.bmj.com | Antonis Fanouriakis |Myrto Kostopoulou |George Bertsias |Dimitrios T. Boumpas
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Nov 21, 2023 | 
mdpi.com | Despoina Kosmara |Sofia Papanikolaou |Christoforos Nikolaou |George Bertsias
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Jul 13, 2023 | 
ard.bmj.com | Antonis Fanouriakis |Nikolaos Tziolos |George Bertsias |Dimitrios T. Boumpas
http://orcid.org/0000-0003-2696-031XAntonis Fanouriakis1, Nikolaos Tziolos2, George Bertsias3,4, http://orcid.org/0000-0002-9812-4671Dimitrios T Boumpas2 1 Department of Rheumatology, Asklepieion General Hospital, Athens, Greece 2 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece 3 Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Iraklio, Greece 4 Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and...
-
May 11, 2023 | 
ard.bmj.com | Christina Adamichou |George Bertsias
http://orcid.org/0000-0001-7374-7795Christina Adamichou1, George Bertsias2,3 1 Rheumatology, University of Crete School of Medicine, Heraklion, Greece 2 Rheumatology, University of Crete School of Medicine, Iraklio, Crete, Greece 3 Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece Correspondence to Dr George Bertsias, Rheumatology, University of Crete School of Medicine, Iraklio, Crete 71008, Greece; gbertsias{at}uoc.gr...
